C9301 Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short descriptor: Obecabtagene car pos t
Look up C9301 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
C9301 is the HCPCS Level II code for Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.
Classification & CMS Attributes
- Section
- C: Outpatient PPS (Hospital)
- Medicare Coverage
- Special coverage instructions apply (code D)
- Part B Pricing
- Statute (indicator 53)
- Type of Service
- Medical care
- Effective Date
- 2025-07-01
- Termination Date
- 2025-06-30
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference C9301 with the canonical source and edition:
C9301 — Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9301
Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9301